Use of anti-thrombotic agents during chemotherapy for epithelial ovarian cancer

被引:8
作者
Salman, MC [1 ]
Ayhan, A [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Obstet & Gynecol, TR-06100 Ankara, Turkey
关键词
D O I
10.1016/j.mehy.2005.11.044
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The association between malignancy and venous thrombotic events is well established. However, arterial thrombosis among cancer patients is extremely rarely reported. There are several mechanisms of arterial thrombosis or embolism in malignancy. Important mechanisms in arterial thrombogenesis are shear stress-induced platelet aggregation and platelet-derived microparticles. Both of these are induced by major abdominal surgery. A major abdominopelvic surgery followed by adjuvant platinum-based combined chemotherapy is routinely performed for epithelial ovarian cancer which is the leading cause of death among all gynecologic malignancies. These patients have a greater risk of arterial thrombosis at the postoperative period. If the affected arteries are relatively larger, clinical findings will be evident due to limb ischemia or fatal organ infarctions. However, thrombosis of the small arteries disturbs the tissue circulation which is extremely important for the chemotherapeutic agents to reach the residual tumor cells. When the thrombosis of small arteries is prevented, these drugs will reach all of the residual macroscopic or microscopic tumoral tissues and so the prognosis of the patients may be improved. Therefore, we hypothesize that anti-platelet therapy with aspirin is needed to be initiated during the postoperative period of epithelial ovarian cancer patients and be continued as tong as chemotherapy goes on. Such an approach might have a role in optimizing the oncological prognosis of these patients via increasing the effectiveness of cytotoxic therapy since some of the recurrences may be caused by some microscopic tumor foci which were not affected by cytotoxic drugs because of subclinical small arterial thromboses. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1179 / 1181
页数:3
相关论文
共 50 条
[41]   Gastrointestinal (GI) Bleeding With Anti-thrombotic Use: A Large Malaysian Cohort Study [J].
Shahrani, Shahreedhan ;
Gill, Sandeep Singh ;
Ng, Xin Tong ;
Looi, Kah Hee ;
Norhisyam, Nurul Safirah ;
Chee, Sher Weyne ;
Khoo, Xin Hui ;
Mahadeva, Sanjiv .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 :360-360
[42]   INCREASE OF VENOUS FLOW VELOCITY IN THE LEG AND PELVIS WITH THE USE OF AN ANTI-THROMBOTIC STOCKING [J].
PARTSCH, H ;
KAHN, P .
HELVETICA CHIRURGICA ACTA, 1983, 50 (1-2) :17-19
[43]   Anti-Thrombotic Therapy for Ambulatory Patients with Multiple Myeloma Receiving Immunomodulatory Agents: A Systematic Review [J].
Matar, Charbel .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S445-S445
[44]   Laparoscopic surgery in colon cancer patients treated with chronic anti-thrombotic therapy [J].
Nozawa, Hiroaki ;
Shinagawa, Takahide ;
Kawai, Kazushige ;
Hata, Keisuke ;
Tanaka, Toshiaki ;
Nishikawa, Takeshi ;
Otani, Kensuke ;
Sasaki, Kazuhito ;
Kaneko, Manabu ;
Emoto, Shigenobu ;
Murono, Koji .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (08) :3509-3516
[45]   Laparoscopic surgery in colon cancer patients treated with chronic anti-thrombotic therapy [J].
Hiroaki Nozawa ;
Takahide Shinagawa ;
Kazushige Kawai ;
Keisuke Hata ;
Toshiaki Tanaka ;
Takeshi Nishikawa ;
Kensuke Otani ;
Kazuhito Sasaki ;
Manabu Kaneko ;
Shigenobu Emoto ;
Koji Murono .
Surgical Endoscopy, 2018, 32 :3509-3516
[46]   Re: Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review [J].
Nigam, Chandni ;
Bladen, J. C. .
EYE, 2021, 35 (05) :1519-1519
[47]   Design and synthesis of new antagonist peptides for platelet GPIIb/IIIa receptor as anti-thrombotic agents [J].
Hayashi, Y ;
Sato, Y ;
Katada, J ;
Takiguchi, Y ;
Ojima, I ;
Uno, I .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (12) :1351-1356
[48]   Do anticholesterolemic drugs act as anti-thrombotic agents? The fluvastatin alone and in combination trial (FACT) [J].
Boschetti, C ;
Cofrancesco, E ;
Cortellaro, M .
THROMBOSIS AND HAEMOSTASIS, 1997, :P1340-P1340
[49]   3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents [J].
Babkov, Denis ;
Bezsonova, Elena ;
Sirotenko, Viktor ;
Othman, Elias ;
Klochkov, Vladlen ;
Sosonyuk, Sergey ;
Lozinskaya, Natalia ;
Spasov, Alexander .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 87
[50]   Re: Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review [J].
Chandni Nigam ;
J. C. Bladen .
Eye, 2021, 35 :1519-1519